Healthcare -
Biotechnology - NASDAQ - US
$ 3.345
1.36 %
$ 634 M
Market Cap
-7.78
P/E
ABUS - STOCK-BASED COMPENSATION
Stock-based Compensation ABUS - Arbutus Biopharma Corporation
9.3 M
LAST VALUE
20.33%
2 YEAR CAGR
8.31%
5 YEAR CAGR
26.27%
10 YEAR CAGR